Stock Price
47.60
Daily Change
-0.58 -1.20%
Monthly
0.68%
Yearly
-12.18%
Q1 Forecast
46.71

Recordati reported EUR384.01M in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Almirall EUR 517.43M 43.18M Jun/2025
GlaxoSmithKline GBP 7.18B 1.42B Dec/2025
Hikma Pharmaceutical USD 642M 663M Jun/2025
Orion EUR 367.1M 64.9M Dec/2025
Sanofi EUR 10.51B 1.21B Dec/2025